MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 111 filers reported holding MYOVANT SCIENCES LTD in Q4 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $294 | -99.8% | 10,900 | 0.0% | 0.00% | – |
| Q3 2022 | $196,000 | +45.2% | 10,900 | 0.0% | 0.00% | – |
| Q2 2022 | $135,000 | -6.9% | 10,900 | 0.0% | 0.00% | – |
| Q1 2022 | $145,000 | -14.7% | 10,900 | 0.0% | 0.00% | – |
| Q4 2021 | $170,000 | -94.7% | 10,900 | -98.2% | 0.00% | – |
| Q3 2019 | $3,189,000 | -67.6% | 613,315 | -43.6% | 0.00% | -100.0% |
| Q2 2019 | $9,836,000 | -49.3% | 1,086,893 | +33.8% | 0.00% | -66.7% |
| Q1 2019 | $19,386,000 | +45.7% | 812,148 | +0.2% | 0.00% | +50.0% |
| Q4 2018 | $13,306,000 | -38.1% | 810,848 | +0.2% | 0.00% | -33.3% |
| Q3 2018 | $21,489,000 | +39.3% | 809,380 | +20.0% | 0.00% | +50.0% |
| Q2 2018 | $15,430,000 | +51.6% | 674,703 | +41.0% | 0.00% | 0.0% |
| Q1 2018 | $10,180,000 | +1631.3% | 478,609 | +929.4% | 0.00% | – |
| Q4 2017 | $588,000 | – | 46,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
| Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
| Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
| Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
| Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
| TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
| DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |